(Q68410483)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383611%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

A pharmacokinetic comparison of controlled-release and standard naproxen tablets (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383611%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

1 reference

N. J. Ryley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383611

3 January 2023

G. Lingam

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383611

3 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3383611

3 January 2023

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383611%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

24 September 2019

http://www.tandfonline.com/doi/pdf/10.1185/03007998809111125

1 reference

https://api.crossref.org/works/10.1185/03007998809111125

Current Medical Research and Opinion

3 January 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383611%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383611%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383611%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

10-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383611%20AND%20SRC:MED&resulttype=core&format=json

Naproxen in osteoarthrosis. Double-blind crossover trial

24 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1185/03007998809111125

Naproxen in rheumatoid arthritis. A controlled trial

3 January 2023

2

1 reference

https://api.crossref.org/works/10.1185/03007998809111125

Ankylosing Spondylitis: Open Long-Term and Double-Blind Crossover Studies with Naproxen

3 January 2023

4

1 reference

https://api.crossref.org/works/10.1185/03007998809111125

A double-blind, multi-centre comparison of naproxen and indomethacin in acute musculo-skeletal disorders

3 January 2023

5

1 reference

https://api.crossref.org/works/10.1185/03007998809111125

Naproxen: A novel approach to dose-flnding efficacy trials in rheumatoid arthritis

3 January 2023

7

1 reference

https://api.crossref.org/works/10.1185/03007998809111125

Drug Defaulting in a General Practice

3 January 2023

9

1 reference

https://api.crossref.org/works/10.1185/03007998809111125

Multicentre trial of naproxen and phenylbutazone in acute gout

3 January 2023

12

1 reference

https://api.crossref.org/works/10.1185/03007998809111125

A double-glind comparative trial of naproxen and indomethacin in sports injuries

3 January 2023

13

1 reference

https://api.crossref.org/works/10.1185/03007998809111125

3 January 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383611%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference